Lucid Diagnostics
In Brief This Week: Natera, Enzo Biochem, Tempus, Vizgen, Complete Genomics, Parse Biosciences, More
News items for the week of Dec. 16, 2024.
The company also recently published multiple new clinical validation studies to support its quest for reimbursement.
Lucid Diagnostics Raises $22M in Convertible Debt Refinancing
The cash raised brings the company’s total holdings to about $33 million, enough to see it through plans to gain reimbursement for its esophageal cancer test.
In Brief This Week: Oncocyte, Lucid Diagnostics, T2 Biosystems, All of Us, Myriad Genetics, More
News items for the week of Nov. 11, 2024
In Brief This Week: Hologic, Illumina, LGC Biosearch, Agilent, Abbott, Eurofins, Centogene, More
News items for the week of Sept. 16, 2024.